Rosuvastatin/Ezetimibe and Ledipasvir/Sofosbuvir Interaction

Drug interaction information between Rosuvastatin/Ezetimibe and Ledipasvir/Sofosbuvir.

Rosuvastatin/Ezetimibe and Ledipasvir/Sofosbuvir have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Rosuvastatin/Ezetimibe and Ledipasvir/Sofosbuvir. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Rosuvastatin/Ezetimibe

Statin / Cholesterol Absorption Inhibitor

Drug B

Ledipasvir/Sofosbuvir

NS5A/NS5B Inhibitor (HCV)

How They Interact

These medications can cause rosuvastatin to build up in your system, which increases the risk of harmful side effects.

FDA Label Information

Intervention: Sofosbuvir/velpatasvir/voxilaprevir Ledipasvir/sofosbuvir Avoid concomitant use with rosuvastatin.

Ledipasvir/Sofosbuvir Also Interacts With

View all Ledipasvir/Sofosbuvir interactions →

Frequently Asked Questions

What SPL severity band is on file for Rosuvastatin/Ezetimibe + Ledipasvir/Sofosbuvir?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Ledipasvir/Sofosbuvir has 22 labeled pairs on file vs Rosuvastatin/Ezetimibe's 12. In the moderate band specifically: Rosuvastatin/Ezetimibe has 7 (also Rosuvastatin, Cyclosporine, Colchicine, Gemfibrozil); Ledipasvir/Sofosbuvir has 5 (also Atorvastatin, Rifampin, Amiodarone, Rosuvastatin).

What mechanism field is on file for Rosuvastatin/Ezetimibe and Ledipasvir/Sofosbuvir?

These medications can cause rosuvastatin to build up in your system, which increases the risk of harmful side effects.

Rosuvastatin/Ezetimibe carries more major-labeled pairs than Ledipasvir/Sofosbuvir

SPL source-record counts only. This page's band is moderate · classes on file: Rosuvastatin/Ezetimibe (Statin / Cholesterol Absorption Inhibitor); Ledipasvir/Sofosbuvir (NS5A/NS5B Inhibitor (HCV)).

Rosuvastatin/Ezetimibe has 3 major-labeled pairs vs Ledipasvir/Sofosbuvir's 0. This page itself is in the moderate band, not the major band.

Rosuvastatin/Ezetimibe

3 major · 7 moderate · 2 minor · 12 total

Ledipasvir/Sofosbuvir

0 major · 5 moderate · 17 minor · 22 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.